Turnstone Biologics Corp (TSBX)’s valuation ratios: A closer look

The closing price of Turnstone Biologics Corp (NASDAQ: TSBX) was $2.62 for the day, down -7.42% from the previous closing price of $2.83. In other words, the price has decreased by -$0.2100 from its previous closing price. On the day, 255925 shares were traded.

Ratios:

Our analysis of TSBX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.57 and its Current Ratio is at 8.57. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.

On August 15, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $20.

On August 15, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $18.BofA Securities initiated its Buy rating on August 15, 2023, with a $18 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 25 ’23 when Jerel Davis bought 225,000 shares for $12.00 per share. The transaction valued at 2,700,000 led to the insider holds 2,726,322 shares of the business.

Versant Ventures V, LLC bought 225,000 shares of TSBX for $2,700,000 on Jul 25 ’23. The 10% Owner now owns 2,726,322 shares after completing the transaction at $12.00 per share. On Jul 20 ’23, another insider, ORBIMED ADVISORS LLC, who serves as the Director of the company, bought 416,666 shares for $12.00 each. As a result, the insider paid 4,999,992 and bolstered with 3,099,265 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TSBX now has a Market Capitalization of 65.37M and an Enterprise Value of -26.19M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.13 while its Price-to-Book (P/B) ratio in mrq is 0.61. Its current Enterprise Value per Revenue stands at -1.36 whereas that against EBITDA is 0.47.

Stock Price History:

Over the past 52 weeks, TSBX has reached a high of $13.20, while it has fallen to a 52-week low of $1.62. The 50-Day Moving Average of the stock is 2.9711, while the 200-Day Moving Average is calculated to be 4.5203.

Shares Statistics:

TSBX traded an average of 163.91K shares per day over the past three months and 197.82k shares per day over the past ten days. A total of 23.10M shares are outstanding, with a floating share count of 13.21M. Insiders hold about 42.83% of the company’s shares, while institutions hold 34.16% stake in the company. Shares short for TSBX as of Mar 15, 2024 were 438.03k with a Short Ratio of 2.67, compared to 342.34k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.90% and a Short% of Float of 2.71%.

Earnings Estimates

The firm’s stock currently is rated by 2 analysts. The consensus estimate for the next quarter is -$0.92, with high estimates of -$0.73 and low estimates of -$1.11.

Analysts are recommending an EPS of between -$2.42 and -$4.49 for the fiscal current year, implying an average EPS of -$3.32. EPS for the following year is -$3.33, with 2 analysts recommending between -$2.74 and -$3.92.

Most Popular